In vivo studies have started

In vivo studies have started.

We have now taken one of the most important steps so far in our gene therapy program for Friedreich’s ataxia. The first mice have been dosed, and our in vivo studies have officially begun.

This marks the transition from design and preparation to true biological testing in a living system. It allows us to study how the therapy behaves in vivo, how the frataxin gene is expressed in relevant tissues, and to begin assessing safety and biological effect in a controlled preclinical setting.

At the same time, we know that this is only the beginning. In vivo studies take time, and it will be several months before reliable and complete results can be generated. As the program progresses, we will share updates and insights whenever possible.

This is a critical step on the path toward Proof of Concept. The next major phase will be the planned toxicology studies later this spring, an essential requirement to advance the therapy toward clinical trials. Preparations for this stage are already underway, although full funding has not yet been secured. We therefore continue to gather support and resources to ensure we can move forward without delay.

We move ahead step by step, with humility, determination, and one single focus: the children.
For every child waiting for a chance at life.
This is why we do this.


Update from the lab

AAV Virus Production

This video shows part of the AAV virus production workflow in the lab, where the virus is generated and prepared for downstream processing. This is the platform used to deliver the functional FXN gene to cells.


An evening of laughter in support of FA

An evening of laughter in support of FA

All proceeds go directly to CureFAchildren’s gene therapy program at UTSW –  to create hope for everyone living with Friedreich’s ataxia (FA).


We’ve reached Phase 2 – thanks to you!

We’ve reached Phase 2 – thanks to you!

Thank you to everyone who has stood by us in this fight – you are our heroes. You’ve carried us this far. Every single contribution has made a difference. You’ve helped us fight for a treatment not only for Tom & Lev – but for all children with Friedreich’s Ataxia. You’ve reached out your hand and shown what humanity truly means. Because this isn’t just a medical issue. It’s a humanitarian one.

Thanks to you, we’ve raised SEK 2.5 million – through GoFundMe, Swish, and cureFAchildren.com.
We now move forward with cell testing and AAV production. But the fight continues. The next phase is safety & efficacy studies in mice. That’s why we’re raising the GoFundMe goal.

Please share and help us show what we can do – together.

With love, hope, and deep gratitude,
Zardasht, Helena, Tom & Lev ❤️‍


A parent-led nonprofit on an urgent mission.
Every donation goes directly to research.

Donate now

SWISH: +123 291 07 27
Bankgiro: 893-5744

CURE FA CHILDREN
Org. No. 802551-2255

A parent-led nonprofit on an urgent mission.
Every donation goes directly to research.

Donate now

SWISH: +123 291 07 27
Bankgiro: 893-5744

CURE FA CHILDREN
Org. No. 802551-2255

Contact us

Share our story

Privacy Preference Center